Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults

NCT05441410 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Pyronaridine Tetraphosphate, Artesunate Drug Combination
BIOLOGICAL: PfSPZ Challenge (NF54)
BIOLOGICAL: MVA ME-TRAP
BIOLOGICAL: ChAd63 ME-TRAP
BIOLOGICAL: Sodium chloride (NaCl) 0.9%

Sponsor

University Hospital Tuebingen

Collaborators

[object Object]
[object Object]